Kryza, David
Vinceneux, Armelle
Bidaux, Anne-Sophie
Garin, Gwenaelle
Tatu, Delphine
Cropet, Claire
Badel, Jean-Noël
Perol, David
Giraudet, Anne-Laure
Article History
Received: 24 November 2023
Accepted: 30 November 2023
First Online: 1 February 2024
Declarations
:
: This study has obtained ethical approval from both the “Comité de Protection des Personnes Sud Est” in August 2023 and the National Agency for Medical Health Products Safety (project reference 2022-502440-12-00) in August 2023. Prior to the commencement of any study-related assessments, written informed consent will be obtained from all participating patients.
: Not applicable.
: The authors declare no competing interests.
: ALG, DK, AV contributed to the conceptual design of the study and protocol. GG, ASB, CC, DT, JNB and DP were significant contributors to the further development of the protocol. Additionally, all authors will actively participate in the execution of the clinical trial. Each author has thoroughly reviewed and endorsed the final manuscript.